A clinical trial to study the effect of two drugs, Rasnadidashmool kwatha and Erandadi kwath in patients of Amavata (Rheumatoid Arthritis).
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: null- Patients of Amavata without any other co-existing disease
- Registration Number
- CTRI/2018/01/011537
- Lead Sponsor
- Ch Brahm Prakash Ayurved Charak Sansthan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1-Amavata of any dosha Anubandha
2-Diagnosis of Amavata as per symptoms described in Madhav Nidana
3-Diagnosis of Rheumatoid arthritis as per ACR criteria
Exclusion Criteria
1-Pregnant women and lactating mother
2-Patients of RA with know case of rheumatic fever juvenile RA, Ankylosing spondylitis
3-Patients of RA with complications like deformity
4-Any other disorder with Amavata
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptomatic relief in cardinal signs and symptoms of patients <br/ ><br>Improvement in DAS-28 ScoreTimepoint: 35 days
- Secondary Outcome Measures
Name Time Method Subjective improvement in the patients will be assessed by adopting suitable scoring pattern. <br/ ><br>Decrease in elevated levels of CRP,ESR,RA factor and other biochemical parameters. <br/ ><br>Assessment of grip strength and walking time by suitable method.Timepoint: 35 days